InvestorsHub Logo
Followers 10
Posts 1578
Boards Moderated 0
Alias Born 10/15/2014

Re: Doctor Detroit post# 7274

Monday, 02/01/2016 2:27:17 PM

Monday, February 01, 2016 2:27:17 PM

Post# of 16911
Anyone do the math on a 2018 launch of probuphine for chronic pain from the Braeburn presentation?

Assuming they were approved on December 31, 2018, I don't think they'd get priority review so that's one year for FDA review (2018) , and at least a year or so for the Phase III trials (2017)...so initiation of the trials could occur in 2016. This really could be an awesome year.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News